Production (Stage)
Xylem Inc.
XYL
$124.05
-$1.22-0.97%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.77% | 6.52% | 1.35% | 25.96% | 40.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.77% | 6.52% | 1.35% | 25.96% | 40.40% |
| Cost of Revenue | 1.56% | 2.72% | 0.61% | 26.05% | 42.02% |
| Gross Profit | 2.13% | 13.36% | 2.62% | 25.81% | 37.73% |
| SG&A Expenses | -2.95% | 37.46% | -9.55% | 8.97% | 34.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.17% | 9.07% | -2.41% | 20.25% | 38.66% |
| Operating Income | 15.14% | -5.75% | 34.60% | 87.07% | 56.83% |
| Income Before Tax | 10.71% | 78.57% | 45.41% | 116.67% | 55.56% |
| Income Tax Expenses | 16.28% | 187.50% | 57.58% | 140.91% | 59.26% |
| Earnings from Continuing Operations | 9.15% | 22.56% | 42.76% | 110.87% | 54.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.46% | 22.56% | 42.76% | 110.87% | 54.55% |
| EBIT | 15.14% | -5.75% | 34.60% | 87.07% | 56.83% |
| EBITDA | 12.50% | -3.19% | 18.72% | 75.73% | 76.88% |
| EPS Basic | 9.90% | 21.69% | 41.57% | 78.69% | 15.27% |
| Normalized Basic EPS | 18.43% | -7.80% | 32.37% | 60.51% | 17.45% |
| EPS Diluted | 9.52% | 21.05% | 41.27% | 78.69% | 16.67% |
| Normalized Diluted EPS | 18.69% | -7.64% | 32.64% | 60.80% | 17.47% |
| Average Basic Shares Outstanding | 0.52% | 0.72% | 0.86% | 18.02% | 34.07% |
| Average Diluted Shares Outstanding | 0.31% | 0.54% | 0.64% | 17.80% | 34.03% |
| Dividend Per Share | 11.11% | 9.09% | 9.09% | 9.09% | 9.09% |
| Payout Ratio | 0.01% | -0.11% | -0.23% | -0.48% | -0.05% |